A booster dose of the Pfizer/BioNTech vaccine was found to have a 95.6% efficacy against Covid-19 in a Phase 3 trial, the companies announced. They noted that 'efficacy was consistent irrespective of age, sex, race, ethnicity or comorbid conditions.'
A booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy -- 95.6% -- against Covid-19 in a Phase 3 trial, the companies announced on Thursday. They noted that"efficacy was consistent irrespective of age, sex, race, ethnicity or comorbid conditions."
CDC advisers recommend booster doses of Covid-19 vaccine for certain adults only The trial included more than 10,000 fully vaccinated people, age 16 and older, who randomly received either the 30-microgram booster dose of vaccine or a placebo. The median time between completing their initial second dose of vaccine and receiving a booster or placebo was about 11 months, the companies said.
Then on Wednesday, the FDA authorized the Pfizer/BioNTech booster for those who may be eligible but are fully vaccinated with either the Moderna or Johnson & Johnson coronavirus vaccines, as a mix-and-match approach.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer, BioNTech report high efficacy of COVID-19 booster shot in studyPfizer Inc and German partner BioNTech SE on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of their COVID-19 vaccine against the virus, including the Delta variant.
Read more »
Pfizer Says Its Booster Shot Shows 95.6% Efficacy Against Covid-19I am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Read more »
Pfizer, BioNTech report high efficacy of COVID-19 booster shot in studyPfizer Inc and German partner BioNTech SE on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of their COVID-19 vaccine against the virus, including the Delta variant.
Read more »
FDA OKs mixing COVID vaccines; backs Moderna, J&J boostersWASHINGTON (AP) — U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.
Read more »
White House rolls out plan to vaccinate kids ages 5 to 11 against CovidAn FDA advisory committee is expected to meet next week to discuss Pfizer and BioNTech's request to authorize their vaccine for children in that age range.
Read more »
Can I get a COVID-19 vaccine booster shot? Here's who can get them and where.So far, 8.8 million Americans have received a booster dose of the Pfizer vaccine. Here’s everything to know about booster doses of all three vaccines.
Read more »